Reviews and feature articleFilaggrin in atopic dermatitis
Section snippets
FLG expression and function
The giant inactive precursor profilaggrin is a large, complex, highly phosphorylated polypeptide that is the main constituent of the keratohyalin F granules that are visible in the granular cell layer of the epidermis (Fig 1, A). During formation of the cornified cell envelope, profilaggrin is dephosphorylated and proteolytically cleaved by serine proteases, including channel-activating serine protease/Prss and matriptase/matriptase, to release multiple copies of the functional FLG repeat
FLG mutations confer strong genetic susceptibility to eczema
The discovery of the association of FLG mutations with atopic diseases followed insights into a common disorder of keratinization, ichthyosis vulgaris (IV). IV is the most common of the ichthyotic disorders, estimated to affect 1 in 250 individuals, and is characterized by generalized fine white scale, palmoplantar hyperlinearity, and keratosis pilaris. For more than 20 years, much indirect evidence pointed toward mutations in FLG as causative; however, many confounders delayed confirmation of
FLG: Epistatic effects?
Other genetic associations within pathways that modulate filaggrin have been reported, including common maternally derived polymorphisms in the serine protease inhibitor SPINK5 (particularly Glu420Lys) that have been shown to modify the risk of eczema, asthma, and IgE, suggesting that this pathway might lie in altered expression of environmental proteases. Pathologic loss-of-function mutations in SPINK5, as found in patients with Netherton syndrome, are associated with a profound barrier defect
FLG and eczema pathogenesis: Mechanisms and speculations
Although the very strong genetic association of FLG mutations with eczema is now clear, the mechanistic pathways from inherited FLG haploinsufficiency to the typical inflammatory lesions of eczema requires further elucidation. FLG deficiency leads to reduced NMF,23 which is likely a contributor to the xerotic phenotype seen in many patients with eczema. The initiation of the typical inflammatory response is of great interest, and with this in mind, one should remember that around 40% of all
Conclusion
FLG mutations are the strongest and most widely replicated genetic risks for eczema identified to date. They have a clear permissive effect in the early inflammatory effects that characterize eczema and affect both priming of disease and chronicity. The identification of these mutations has enlivened the field of eczema genetics. Their identification raises the potential for targeted intervention and therapy and might lead to a consideration of a new molecular classification of eczema. The
References (25)
- et al.
Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (“epidermal differentiation complex”) on human chromosome 1q21
J Invest Dermatol
(1996) - et al.
Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms
J Allergy Clin Immunol
(2008) - et al.
Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations
J Allergy Clin Immunol
(2006) - et al.
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march
J Allergy Clin Immunol
(2006) - et al.
Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis
J Invest Dermatol
(2007) Fleshing out filaggrin phenotypes
J Invest Dermatol
(2007)- et al.
Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data
J Allergy Clin Immunol
(2007) - et al.
Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis
J Invest Dermatol
(2006) - et al.
Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum
J Invest Dermatol
(2008) - et al.
Cytokine modulation of atopic dermatitis filaggrin skin expression
J Allergy Clin Immunol
(2007)
Antimicrobial peptides and the skin immune defense system
J Allergy Clin Immunol
The cornified envelope: a model of cell death in the skin
Nat Rev Mol Cell Biol
Cited by (301)
Atopic dermatitis: Pathophysiology, microbiota, and metabolome – A comprehensive review
2024, Microbiological ResearchLoricrin and Cytokeratin Disorganisation in Severe Forms of Periodontitis
2023, International Dental JournalPediatric chronic hand eczema: Epidemiology, clinical presentation, and management
2023, JAAD InternationalA comparison of electrosprayed vs vortexed glycosaminoglycan-peptide nanoparticle platform for protection and improved delivery of therapeutic peptides
2023, Colloids and Surfaces B: BiointerfacesPediatric dermatology and common skin conditions
2023, Encyclopedia of Child and Adolescent Health, First EditionEpithelial barrier regulation, antigen sampling, and food allergy
2022, Journal of Allergy and Clinical Immunology
Disclosure of potential conflict of interest: W. H. I. McLean has received research support from DEBRA UK and the Medical Research Council. The rest of the authors have declared that they have no conflict of interest.